Visiongain Publishes Rare Diseases Market Report 2023-2033

The global Rare Diseases market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033.

Visiongain Publishes Biopreservation Market Report 2023-2033

The global Biopreservation market was valued at US$5,379.5 million in 2022 and is projected to grow at a CAGR of 9.86% during the forecast period 2023-2033.

Visiongain Publishes Pre-Filled Syringes Market Report 2023-2033

The global Pre-Filled Syringes market was valued at US$3,944.2 million in 2022 and is projected to grow at a CAGR of 8.41% during the forecast period 2023-2033.

Visiongain Publishes Fill-Finish Manufacturing Market Report 2023-2033

The global Fill-Finish Manufacturing market was valued at US$9,383.0 million in 2022 and is projected to grow at a CAGR of 9.2% during the forecast period 2023-2033.

Visiongain Publishes Gynaecology Drugs Market Report 2023-2033

The global Gynaecology Drugs market was valued at US$43,561 million in 2023 and is projected to grow at a CAGR of 5.1% during the forecast period 2023-2033.

Visiongain Publishes Surgical Robots Market Report 2023-2033

The global Surgical Robots market was valued at US$8.40 billion in 2022 and is projected to grow at a CAGR of 19% during the forecast period 2023-2033.

Visiongain Publishes Antibiotics Market Report 2023-2033

The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.

Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033

The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.

Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033

The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.

Visiongain Publishes Human Microbiome Market Report 2023-2033

The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

Visiongain Publishes Allergic Rhinitis Drugs Market Report 2023-2033

The global Allergic Rhinitis Drugs market was valued at US$12,025.2 million in 2022 and is projected to grow at a CAGR of 3.78% during the forecast period 2023-2033.

Visiongain Publishes Women’s Health Market Report 2023-2033

The global Women’s Health market was valued at US$36,567.3 million in 2022 and is projected to grow at a CAGR of 4.1% during the forecast period 2023-2033.

Visiongain Publishes Biodefence Market Report 2023-2033

The global Biodefence market was valued at US$14,675.0 million in 2022 and is projected to grow at a CAGR of 7.78% during the forecast period 2023-2033.

Visiongain Publishes Neurotech Devices Market Report 2023-2033

The global Neurotech Devices market was valued at US$11,582.1 million in 2022 and is projected to grow at a CAGR of 13.78% during the forecast period 2023-2033.

Visiongain Publishes Wearable Brain Devices Market Report 2023-2033

The global Wearable Brain Devices market was valued at US$276.0 million in 2022 and is projected to grow at a CAGR of 11.4% during the forecast period 2023-2033.

Visiongain Publishes Asthma & COPD Therapies Market Report 2023-2033

The global Asthma & COPD Therapies market is estimated to be valued at US$47.85 billion in 2023 and is projected to grow at a CAGR of 7.31% during the forecast period 2023-2033.

Visiongain Publishes Point of Care Diagnostics Market Report 2023-2033

The global Point of Care Diagnostics market is estimated to be valued at US$43.05 billion in 2023 and is projected to grow at a CAGR of 8.8% during the forecast period 2023-2033.

Visiongain Publishes Infectious Disease Diagnostics Market Report 2022-2032

The global Infectious Disease Diagnostics market was valued at US$ 28,272.2 million in 2021 and is projected to grow at a CAGR of 6.61% during the forecast period 2022-2032.

Visiongain Publishes Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

The global Monoclonal Antibody Discovery and Analysis market was valued at US$5,234 million in 2021 and is projected to grow at a CAGR of 9.0% during the forecast period 2022-2032.

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2022-2032

The global CMO of Sterile Injectable Drugs market was valued at US$19,090.4 million in 2021 and is projected to grow at a CAGR of 9.10% during the forecast period 2022-2032.

Clients & Partners

BP logo Kelloggs logo BAE systems logo Unilever logo BASF logo 3M logo THALES logo TEVA logo Shell logo Raytheon logo Pfizer logo Lockhead Martin logo Mercedes logo Honeywell logo DUPONT logo Daimler logo Deloitte logo